Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.

doi:10.1038/s41375-020-0727-y

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.

Leukemia - 1 Apr 2020

Hoechstetter Manuela A, Busch Raymonde, Eichhorst Barbara, Bühler Andreas, Winkler Dirk, Bahlo Jasmin, Robrecht Sandra, Eckart Michael J, Vehling-Kaiser Ursula, Jacobs Georg, Jäger Ulrich, Hurtz Hans Jürgen, Hopfinger Georg, Hartmann Frank, Fuss Harald, Abenhardt Wolfgang, Blau Ilona, Freier Werner, Müller Lothar, Goebeler Maria, Wendtner Clemens, Fischer Kirsten, Herling Carmen D, Starck Michael, Bentz Martin, Emmerich Bertold, Döhner Hartmut, Stilgenbauer Stephan, Hallek Michael

Abstract excerpt

The heterogeneity of early stage CLL challenges prognostication, and refinement of prognostic indices for risk-adapted management in this population is essential. The aim of the multicenter, prospective CLL1 trial was to explore a novel prognostic model (CLL1-PM) developed to identify risk groups, separating patients with favorable from others with dismal prognosis. A cohort of 539 clinically, biochemically, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Disease Progression

Share to Follow-Up Studies

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Prognosis

Share to Risk Factors

Share to Survival Rate

Source

Open in PubMed

Identifiers

PMID: 32042081
DOI: 10.1038/s41375-020-0727-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.PMID 32042081Read ↗

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.Semantic proximity Read ↗

Predicting Stage Progression in Binet Stage a Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.Semantic proximity Read ↗

Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemiaSemantic proximity Read ↗

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.Semantic proximity Read ↗

Using prognostic models in CLL to personalize approach to clinical care: Are we there yet?Semantic proximity Read ↗

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemiaSemantic proximity Read ↗

Chronic Lymphocytic Leukemia: Prognostic/Predictive Factors in the Era of Novel DrugsSemantic proximity Read ↗

MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.Semantic proximity Read ↗

Defining the prognosis of early stage chronic lymphocytic leukaemia patients.Semantic proximity Read ↗

Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?Semantic proximity Read ↗

Risk-Adapted Therapy in Early-Stage Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.